Bioinformatics: Technologies and Global Markets

  • ID: 3632950
  • Report
  • Region: Global
  • 158 pages
  • BCC Research
20 % OFF
until Jun 30th 2018
1 of 4
The Global Bioinformatic Market is Expected to Reach $8.0 billion in 2019 from $4.7 billion in 2015 at a CAGR of 14.2% for the Period 2014-2019
This report provides a comprehensive analysis of the bioinformatic market by reviewing the recent advances in high throughput 'omic platforms and computer enabled tools that drive the field forward. Includes forecast through 2019.

The report provides:

- An overview of the global market for bioinformatics based on geography, category and application
- Analyses of global market trends, with data from 2013 and 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2019
- Technological descriptions and patenting trends in bioinformatics
- Analysis of the market's dynamics, including opportunities, drivers, and restraints
- Examination of the economic environment effecting the deployment of bioinformatics
- Discussion of other influential factors, such as R&D spending in the pharmaceutical sector, the growth of agrobiotechnology, and the expanded use of microbial genomics
- Comprehensive company profiles of major players in the industry

Scope of the Report:

The scope of the study encompasses the global bioinformatic market based on geography, category and application. It provides a detailed analysis of recent advances in ‘omic technologies and examines their impact on the bioinformatic market. It discusses the ways in which bioinformatics has been utilized by the pharma and biotech industry to streamline the research and development (R&D) process and improve efficiencies. It provides a detailed analysis of leading countries, companies and technologies that will drive the field forward.

Study Goals and Objectives:

The goal for this study is to provide a comprehensive analysis of the bioinformatic market by reviewing the recent advances in high-throughput ‘omic platforms and computer-enabled tools that drive the field forward. It examines the market trends and provides analysis regarding industry service providers and software solution developers, as well as IT and bioinformatics service providers that support the pharma and biotech industry.

The report’s main focus is to identify the challenges and opportunities that exist in the bioinformatic market following the adoption of high-throughput technologies such as next-generation sequencing (NGS), the analysis of big data and the emergence of cloud-based solutions. It identifies innovative companies and technologies that are moving the field forward and enabling scientists to search for elusive pieces of information that will improve diagnosis and treatment with precision medicines.

Use this report to:

- Identify the challenges and opportunities that exist in the bioinformatic market
- Analyze industry service providers and software solution developers, as well as IT and bioinformatics service providers
- Analyze recent advances in ‘omic technologies and examines their impact on the bioinformatic market
- Learn about the ways in which bioinformatics has been utilized by the pharma and biotech industry to streamline the research and development (R&D) process and improve efficiencies

Highlights:

- The global bioinformatic market was $3.6 billion and $4.1billion in 2013 and 2014, respectively. This market is expected to reach $8.0 billion in 2019 from $4.7 billion in 2015 at a compound annual growth rate of 14.2% for the period 2014-2019.
- The North American market is expected to grow from nearly $2.6 billion in 2015 to $4.5 billion in 2019 at a CAGR of 15.2% for the period 2014-2019.
- The European market will grow from nearly $1.1 billion in 2015 to $1.7 billion in 2019 at a CAGR of 12.0% for the period 2014-2019.

Intended Audience:

The study provides a detailed analysis of the economic, technological and potential application of bioinformatics; it also examines the market drivers and identifies the potential opportunities through 2019. The study is aimed at the pharmaceutical industry, biotechnology firms, research laboratories and individuals interested in exploiting the commercial opportunities offered in this field.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Chapter- 1: INTRODUCTION
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- SCOPE OF REPORT
- INTENDED AUDIENCE
- INFORMATION SOURCES
- ANALYST'S CREDENTIALS

Chapter- 2: EXECUTIVE SUMMARY
- Table Summary : GLOBAL BIOINFORMATIC MARKET BY REGION, THROUGH 2019
- Figure Summary : GLOBAL BIOINFORMATIC MARKET BY REGION, 2013-2019

Chapter- 3: BIG DATA: WHAT TO DO WITH IT?
- GOAL OF BIOINFORMATICS
- MARKET TRENDS
- MARKET CHALLENGES
- CURRENT MARKET
- MARKET BY REGION
- MARKET BY CATEGORY
- MARKET BY APPLICATION

Chapter- 4: BIOINFORMATICS: DATA GENERATION AND DATA MANAGEMENT
- INFORMATION OVERLOAD
- TECHNOLOGIES BEHIND BIG DATA GENERATION
- GENOMIC ADVANCES
- PROTEOMIC ADVANCES
- METABOLOMIC ADVANCES
- CHEMINFORMATIC ADVANCES
- EMERGING TECHNOLOGIES
- METAGENOMIC ADVANCES
- EPIGENOMIC ADVANCES
- PHARMACOGENOMIC ADVANCES
- TOXICOGENOMIC ADVANCES
- DATABASE MANAGEMENT SERVICES
- MARKET DYNAMICS

Chapter- 5: BIOINFORMATICS: DATA ANALYSIS AND SOFTWARE
- INTRODUCTION
- DATA ANALYSIS SOFTWARE
- BIOSIMULATION MODELS
- MARKET ANALYSIS

Chapter- 6: BIOINFORMATICS: DATA PROCESSING AND STORAGE
- MIND THE GAP
- INFORMATION TECHNOLOGY INFRASTRUCTURE
- HIGH-PERFORMANCE COMPUTING
- HIGH-PERFORMANCE COMPUTER CLUSTERS
- CLOUD COMPUTING
- MARKET ANALYSIS

Chapter- 7: BIOINFORMATIC APPLICATIONS IN PHARMACEUTICAL RESEARCH AND DEVELOPMENT
- INTRODUCTION
- DRUG DISCOVERY AND DEVELOPMENT PROCESS
- CONCLUSIONS

Chapter- 8: MARKET TRENDS AND ANALYSIS
- NORTH AMERICA
- EUROPE
- ASIA-PACIFIC
- CONCLUSIONS

Chapter- 9: COMPANY PROFILES
- 3RD MILLENNIUM INC.
- ASTRID BIOSCIENCE GMBH
- BIOBASE GMBH
- BIOMATTERS LTD.
- CLC BIOINFORMATICS
- CONEXIO GENOMICS PRIVATE LTD.
- COMPUGEN LTD.
- DASSAULT SYSTEMES SA
- DNASTAR INC.
- GEOSPIZA INC.
- GENOMATIX SOFTWARE GMBH
- GVK BIOSCIENCES PRIVATE LTD.
- GENOLOGICS LIFESCIENCES SOFTWARE INC.
- GENEDATA AG
- GENEVA BIOFORMATICS (GENEBIO) SA
- GNS HEALTHCARE INC.
- ILLUMINA INC.
- MOLECULAR CONNECTIONS PRIVATE LTD.
- MOLECULAR NETWORKS GMBH
- NONLINEAR DYNAMICS LTD.
- OCIMUM BIOSOLUTIONS LTD.
- PERKIN ELMER INFORMATICS INC.
- PERSONALIS INC.
- SMARTGENE SERVICES SARL
- REAL TIME GENOMICS INC.

Chapter- 10: APPENDIX ONE: ACRONYMS

Chapter- 11: REFERENCES

ENDNOTES

List of Tables

Summary Table : GLOBAL BIOINFORMATIC MARKET BY REGION, THROUGH 2019
Table 1 : U.S. FOOD AND DRUG ADMINISTRATION AND EUROPEAN MEDICINES AGENCY DRUG APPROVALS, 2009-2014
Table 2 : GLOBAL BIOINFORMATIC MARKET BY REGION, THROUGH 2019
Table 3 : PUBLIC FUNDING PROGRAMS, 2005-2014
Table 4 : GLOBAL BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019
Table 5 : GLOBAL BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019
Table 6 : COMMERCIALLY AVAILABLE METABOLOMIC SOFTWARE
Table 7 : OPEN-ACCESS TOOLS FOR COMPLEX LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY DATA ANALYSIS
Table 8 : CHEMINFORMATIC SOFTWARE SOLUTIONS FOR DRUG RESEARCH AND DEVELOPMENT
Table 9 : BIOINFORMATIC TOOLS FOR METAGENOMIC STUDIES
Table 10 : BIOINFORMATIC TOOLS FOR PHARMACOGENOMIC STUDIES
Table 11 : BIOINFORMATIC TOOLS FOR PHARMACOGENOMIC SOFTWARE
Table 12 : ARCHIVAL DATABASES
Table 13 : CURATIVE DATABASES
Table 14 : COMMERCIALLY AVAILABLE DATABASES
Table 15 : SOFTWARE FOR BIOLOGICAL ANALYSIS
Table 16 : POPULAR COMMERCIALLY AVAILABLE BIOINFORMATIC PROGRAMS FOR NEXT-GENERATION SEQUENCING ANALYSIS
Table 17 : TOP 20 HARDWARE COMPANIES, 2010
Table 18 : TOP SUPERCOMPUTERS, AS OF 2015
Table 19 : SOFTWARE AS A SERVICE RESOURCE
Table 20 : LEADING BIOINFORMATICS DATABASES
Table 21 : LEADING DRUG TARGET DATABASES
Table 22 : COMPUTER SIMULATION PLATFORMS
Table 23 : LEADING LABORATORY INFORMATION MANAGEMENT SYSTEM PROVIDERS
Table 24 : ELECTRONIC NOTEBOOKS USED WITHIN THE RESEARCH AND DEVELOPMENT ENVIRONMENT
Table 25 : ELECTRONIC LABORATORY NOTEBOOKS USED WITHIN SPECIFIC AREAS OF BIOLOGY
Table 26 : LEADING ABSORPTION, DISTRIBUTION, METABOLISM, EXCRETION AND TOXICITY PREDICTION TOOLS
Table 27 : DRUG DEVELOPMENT PROCESS OVERVIEW
Table 28 : LEADING ELECTRONIC HEALTH RECORD PROVIDERS, 2013
Table 29 : MEDICAL APPLICATIONS FOR HEALTHCARE PROFESSIONALS
Table 30 : PHARMACEUTICAL AND BIOINFORMATIC PARTNERSHIPS AND ALLIANCES
Table 31 : NORTH AMERICAN BIOINFORMATIC MARKET BY REGION, THROUGH 2019
Table 32 : LEADING BIOINFORMATIC COMPANIES IN THE U.S.
Table 33 : TOP 15 VENTURE CAPITAL COMPANIES MOST ACTIVE IN THE LIFE SCIENCE SECTOR, THROUGH 2012
Table 34 : U.S. BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019
Table 35 : U.S. BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019
Table 36 : CANADIAN BIOINFORMATIC MARKET BY CATEGORY, THROUGH 2019
Table 37 : LEADING CANADIAN BIOINFORMATIC COMPANIES
Table 38 : CANADIAN BIOINFORMATIC MARKET BY APPLICATION, THROUGH 2019
Table 39 : EUROPEAN BIOINFORMATIC MARKET BY REGION, THROUGH 2019
Table 40 : LEADING EUROPEAN BIOINFORMATIC COMPANIES
Table 41 : U.K. BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019
Table 42 : U.K. BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019
Table 43 : GERMAN BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019
Table 44 : GERMAN BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019
Table 45 : SWISS BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019
Table 46 : SWISS BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019
Table 47 : ASIA-PACIFIC BIOINFORMATIC MARKET BY REGION,THROUGH 2019
Table 48 : INDIAN BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019
Table 49 : LEADING INDIAN BIOINFORMATIC COMPANIES
Table 50 : INDIAN BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019
Table 51 : CHINESE BIOINFORMATIC MARKET BY CATEGORY,THROUGH 2019
Table 52 : CHINESE BIOINFORMATIC MARKET BY APPLICATION,THROUGH 2019

List of Figures

Summary Figure : GLOBAL BIOINFORMATIC MARKET BY REGION, 2013-2019
Figure 1 : RELATIONSHIP OF BIOINFORMATICS WITH 'OMIC TECHNOLOGIES
Figure 2 : SCHEMATIC REPRESENTATION OF BIOLOGY SYSTEMS AND TRANSLATIONAL BIOINFORMATICS
Figure 3 : PRINCIPLES OF PRECISION MEDICINE
Figure 4 : APPLICATIONS OF BIOINFORMATICS ON DRUG DEVELOPMENT
Figure 5 : FOUR DIMENSIONS OF BIG DATA
Figure 6 : TOP-DOWN PROTEOMIC APPROACH
Figure 7 : EUROPEAN BIOINFORMATIC INSTITUTE SOFTWARE SOLUTIONS
Figure 8 : EVOLUTION OF INFORMATION TECHNOLOGY INFRASTRUCTURE
Figure 9 : SCHEMATIC REPRESENTATION OF CLOUD COMPUTING SERVICES
Figure 10 : PHASES IN THE DRUG DISCOVERY AND DEVELOPMENT PROCESS
Figure 11 : BIOINFORMATIC INTERDISCIPLINARY NATURE
Figure 12 : INFORMATION SYSTEMS WITHIN THE LABORATORY ARCHITECTURE
Figure 13 : KEY AREAS OF RESEARCH UTILIZING BIOINFORMATICS
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll